Healthline: Rates of IBD including Crohn’s Disease are three times higher than realized
UC digestive diseases expert discusses treatment options
A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions, Crohn’s Disease and ulcerative colitis.
Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.
Is there anything to fear from Hantavirus?
May 12, 2026
The University of Cincinnati's Carl Fichtenbaum, MD, professor of clinical medicine in the Division of Infectious Diseases in the Department of Internal Medicine at the College of Medicine, recently appeared on Scott Sloan's show on 700 WLW to share facts surrounding Hantavirus.